Drug intelligence / Profile preview

Bostamin

Development stage: Preclinical
Lead developer: TradoMed
Administration: Oral

Overview

Bostamin is an herbal immune booster developed by TradoMed. It is formulated as a botanical remedy intended to provide immune support and enhance the body's natural defense mechanisms. As part of TradoMed's pipeline of traditional and herbal medicines, Bostamin is positioned as a natural intervention for maintaining or improving immune health.

Brand names: Bostamin
Other names: Bostamin

Beyond the preview

Go deeper on Bostamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bostamin.

Explore the full profile